CLONTECH Receives ISO 9001 Certification

May 19, 1999, 01:00 ET from CLONTECH Laboratories, Inc.

    PALO ALTO, Calif., May 19 /PRNewswire/ -- CLONTECH Laboratories, Inc.,
 announced that it has received ISO 9001 Certification in a blanket
 registration that covers its main offices and laboratories in California and
 its worldwide subsidiaries.
     ISO is an acronym for the International Standards Organization based in
 Geneva, Switzerland.  It represents a series of standards for the
 establishment and maintenance of quality systems geared toward promotion of
 international harmonization and international trade.  ISO 9001 is the most
 comprehensive in the series encompassing the design, development and
 manufacturing of products with quality features and characteristics that
 secure a high level of quality in the production of goods and services.
     Dr. Kenneth Fong, President and CEO stated that "achieving this
 certification underscores CLONTECH's commitment to quality management and
 represents a rigorous effort on behalf of employees in all areas of the
 organization for the past year and a half."
     Dr. Fong further stated that "this is an important strategic step in terms
 of extending our commitment to providing innovation and quality products from
 our worldwide facilities.  Our customers will be the ultimate beneficiaries as
 this certification is testimony to the fact that our products are being
 produced under quality controlled processes emphasizing continuous
     About the Company
     CLONTECH Laboratories, Inc., develops, manufactures and markets products
 for life science research.  The company's products enable scientists to
 identify genes, study how cells are regulated by genes and search for drugs
 that can treat diseases.  The company has a portfolio of over 1,500 products
 that allow scientists to perform academic research and drug discovery more
 rapidly and effectively.  Their products are sold primarily to scientists
 within government entities, academic institutions and pharmaceutical and
 biotechnology companies.
     CLONTECH has assembled one of the broadest portfolios of molecular biology
 research tools in the industry.  Their products include enabling technologies,
 which allow scientists to conduct experiments, which would not otherwise be
 possible, and innovative research tools, which permit scientists to achieve
 results in a more rapid, efficient and reproducible manner.  They offer
 products that enable scientists to conduct research in the areas of gene
 identification, gene expression analysis, functional analysis and target
 validation.  For additional corporate information, visit
     CONTACT:  Carol Lou of CLONTECH Laboratories, Inc., 650-424-8222.

SOURCE CLONTECH Laboratories, Inc.